Cannabidiol (CBD) basicsCannabidiol (CBD) is one of the two dominant cannabinoids in the cannabis species. Since its discovery in 1940 CBD has been subject to investigation for its potential to treat a wide range of symptoms and diseases. Unlike its counterpart THC, CBD lacks intoxicating effects which allows for a broader capacity to prescribe in...Read More

For medical practitioners without experience in prescribing medicinal cannabis, the complexities of prescribing CBD oil and cannabis medicines more broadly can be daunting. The sheer number of cannabinoid and other phytochemicals within medical cannabis formulations can be astronomical compared to the isolated compounds found in most pharmaceutical preparations. Additionally, the number of comparative products available...Read More

Many Australians with IBD use cannabis for symptom management – but their doctors aren’t convinced Two recently published surveys on inflammatory bowel disease (IBD) and medicinal cannabis use – one of patients and one of gastroenterologists – conducted  by the University of Sydney’s Lambert Initiative for Cannabinoid Therapeutics in partnership with prominent Australian IBD specialists,...Read More

A new survey published on June 8 2020, the Cannabis as Medicine Survey (CAMS-18), has highlighted that despite legalisation of medicinal cannabis in Australia in late 2016, many Australians are still sourcing illicit cannabis products for medical use. In fact, the survey of over 1300 respondents, found only 25 were using legal prescribed products, with...Read More

Medicinal Cannabis and Wasting Syndrome: What Can It Do?   Cachexia is a condition, also known as ‘wasting syndrome’, characterised by loss of body mass associated with an underlying medical condition such as HIV, tuberculosis, autoimmune conditions, cancer and cancer treatments – to mention a few.   Patients suffering from cachexia, from any underlying condition,...Read More

Australian Law Needs to Catch Up With Medicinal Cannabis Usage By Jessica Kindynis As Australian medical cannabis patient numbers rapidly grow, there is a great need for updated and cohesive laws regarding driving and cannabis. With medical and adult-use increasing in prevalence around the globe, researchers are racing to assess the impact of cannabinoids on...Read More

Untangling GMP in Australia’s Medical Cannabis Landscape There are plenty of acronyms to wrap your head around in the cannabis world and GMP or Good Manufacturing Practice is one that is at the forefront of the industry. Around the globe there’s been a shift towards extract-based products over raw flower for medical cannabis consumption, promoting...Read More

The importance of dosing studies   The emergence of a federally regulated pharmaceutical framework for medicinal cannabis in Australia has resulted in substantial opportunities for medicinal cannabis companies to undertake research and development (R&D) here.    Within the realms of novel drug development, comprehension and accuracy regarding dosage and titration regimens have extreme significance to the...Read More

News Release: Applied Cannabis Research launches study of Cannabinoids and PTSD Applied Cannabis Research is pleased to announce it has received ethics approval for a study into the benefits of cannabinoids and post-traumatic stress disorder (PTSD). The study will commence in May of 2019 and will study up to 300 PTSD patients who have been...Read More

Using Cannabis Clinics for Medical Cannabis Trial Recruitment The age-old problem and one of the biggest hurdles in clinical trials is recruitment. It’s the ultimate rate limiting step which can significantly impact clinical development timelines. As any sponsor of a clinical trial can attest to the most demanding stages of any clinical trial is the...Read More